Doximity Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Doximity stock.
View analyst ratings for Doximity or view top-rated stocks.

Wall Street analysts have given Doximity a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Doximity wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Doximity is scheduled to release its next quarterly earnings announcement on Tuesday, August 10th 2021.
View our earnings forecast for Doximity.

Doximity will be holding an earnings conference call on Tuesday, August 10th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

9 analysts have issued 12-month target prices for Doximity's shares. Their forecasts range from $52.00 to $68.00. On average, they expect Doximity's stock price to reach $61.57 in the next twelve months. This suggests that the stock has a possible downside of 0.5%.
View analysts' price targets for Doximity or view top-rated stocks among Wall Street analysts.

Some companies that are related to Doximity include Cognizant Technology Solutions (CTSH), Zscaler (ZS), EPAM Systems (EPAM), VeriSign (VRSN), NTT DATA (NTDTY), OBIC Co.,Ltd. (OBIIF), Amdocs (DOX), Aspen Technology (AZPN), Endava (DAVA), Compass (COMP), GEMALTO NV/S (GTOMY), Sogou (SOGO), Perficient (PRFT), PROS (PRO) and BTRS (BTRS).
View all of DOCS's competitors.

(DOCS) raised $501 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

Doximity trades on the NASDAQ under the ticker symbol "DOCS."

Doximity's quiet period expires on Tuesday, August 3rd. Doximity had issued 23,300,000 shares in its IPO on June 24th. The total size of the offering was $605,800,000 based on an initial share price of $26.00. During Doximity's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Doximity's stock is owned by many different institutional and retail investors. Top institutional investors include Zweig DiMenna Associates LLC (0.00%). Company insiders that own Doximity stock include Interwest Partners X Lp and Kevin Spain.
View institutional ownership trends for Doximity.

DOCS stock was purchased by a variety of institutional investors in the last quarter, including Zweig DiMenna Associates LLC.
View insider buying and selling activity for Doximity or or view top insider-buying stocks.

Shares of DOCS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DOCS stock can currently be purchased for approximately $61.90.

Doximity has a market capitalization of $11.03 billion.

Doximity employs 713 workers across the globe.

The official website for Doximity is www.doximity.com.

The company can be reached via phone at 650 549 4330 or via email at [email protected]